← All trials
NCT04370288
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 19, 2020
- Primary completion
- Sep 20, 2020
- Completion date
- Sep 21, 2020
- First posted
- Apr 30, 2020
- Last posted
- May 4, 2020
- Enrollment
- 20
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Mashhad University of Medical SciencesLead sponsor
- Mashhad University of Medical SciencesOverall official - principal investigator
- Mashhad University of Medical SciencesReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.